Vincenzo Formica

Effects of conventional therapeutic interventions on the number and function of regulatory T cells

Mario Roselli, Vittore Cereda, Maria Giovanna di Bari et al. · OncoImmunology · 2013 · 184 citations · Full text

Cell Therapy, T-regulatory Cell, Immunology +22

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 110 citations · Full text

Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio

Patrizia Ferroni, Silvia Riondino, Vincenzo Formica et al. · International Journal of Cancer · 2014 · 86 citations · Full text

Prognosis, Pathology, Thrombosis +19

Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy.

Fiorella Guadagni, Patrizia Ferroni, Raffaele Palmirotta et al. · PubMed · 2007 · 83 citations

Tyrosine Kinase, Immunology, Pathology +20

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab

Vincenzo Formica, Raffaele Palmirotta, Girolamo Del Monte et al. · International Journal of Colorectal Disease · 2010 · 81 citations · Full text

Medicine, Pathology, Colorectal Cancer +5